Advent International has appointed Dr. Günter von Au, a longstanding executive board chairman of Süd-Chemie AG, to its Operating Partner Programme. Au will advise Advent on investment opportunities within the chemical sector, the firm said. He will also help support the business development of Advent’s existing portfolio companies.
Frankfurt, April 2, 2012 – Advent International, the global private equity firm, today announced that it has appointed Dr. Günter von Au – longstanding executive board chairman of Süd-Chemie AG – to its Operating Partner Programme. As a leading authority on the international chemical industry, Dr. von Au will advise Advent on investment opportunities within the sector. He will also use his expertise to support the business development of Advent’s existing portfolio companies.
Dr. von Au’s industry expertise spans several decades, during which he has acquired extensive management experience. Before becoming chairman of Süd-Chemie AG in 2004, he spent three years leading the US subsidiary Süd-Chemie Inc. in Louisville, Kentucky. Prior to that, he spent over 20 years in various management roles at Wacker Chemie and its subsidiaries in the areas of research and development (R&D), quality assurance (QA), production, marketing and sales. From 1996 to 2001, he headed up the polymer division and was spokesperson of the management board of Wacker Polymer Systems GmbH. In addition, he held supervisory board mandates at subsidiaries of the group. As early as 1983 to 1987, he served as Technical Director for Wacker Química do Brasil Ltda. in São Paulo.
Dr. von Au is chairman of the board of the Bavarian Chemical Industry Association and a management board member and vice president of the Cologne Institute for Economic Research. He is also a member of the senate of both the Fraunhofer Society and the National Academy of Science and Engineering (acatech) and, in addition, has taken on the role of deputy chairman of the Clariant AG Supervisory Board on April 1, 2012.
Ronald Ayles, Managing Director and Head of Advent´s Chemicals practice said: “We are delighted that Dr. von Au will be supporting us in the future with his extensive industry experience. He is a high-profile individual in the chemical industry who has developed a fundamental understanding of the market and its structures over three decades and has an excellent international network. For over 20 years, Advent International has been building up a successful track record of investments in the chemical industry – this sector has always been of particular interest to us, which makes Dr. von Au a good partner for us.”
“Advent International is among the most renowned private equity companies with a very diversified and interesting portfolio of chemical investments. Advent continually seeks to develop its investments both strategically and operationally which offers me an attractive new challenge. I am already looking forward to leveraging my experience and working with Advent as we pursue new investment opportunities in the chemical space”, commented Dr. Günter von Au.
This is the latest appointment to Advent’s Operating Partner Programme, a long-established and successful element of the firm’s highly operational approach to investing. The programme includes circa 70 senior industry executives, many of whom have been involved in multiple Advent investments. These executives typically assist in activities such as finding attractive investment opportunities, conducting due diligence, and creating and driving value creation plans for Advent’s portfolio companies.
About Advent International
Founded in 1984, Advent International is one of the world’s leading global buyout firms, with offices in 16 countries on four continents. A driving force in international private equity for 27 years, Advent has built an unparalleled global platform of over 160 investment professionals across Western and Central Europe, North America, Latin America and Asia. The firm focuses on international buyouts, strategic repositioning opportunities and growth buyouts in five core sectors, working actively with management teams to drive revenue growth and earnings improvements in portfolio companies. Since inception, Advent has raised €19.4 billion in private equity capital and, through its buyout programmes, has completed over 270 transactions in 35 countries.
The company’s existing investments in the chemical sector include Oxea, H.C. Starck and Vinnolit in Germany, Maxam in Spain, as well as Mondo Minerals in France.